𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical outcome of parosteal osteosarcoma

✍ Scribed by Ilkyu Han; Joo Han Oh; Yeong Gon Na; Kyung Chul Moon; Han-Soo Kim


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
119 KB
Volume
97
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Parosteal osteosarcoma is a rare type of osteosarcoma with distinct characteristics. Clinical outcome of 21 patients was analyzed to assess the predictive relevance of surgical margin, intramedullary tumor extension and histologic grade.

Methods

There were 5 mens and 16 womens with an average age of 26 years. Average follow‐up was 9.1 years (range 2.5–22.1). Most common sites were distal femur (15) and proximal humerus (2). No patient presented with metastasis. Surgical margin was wide in 13 and marginal in 8. Intramedullary extension was seen in 10 patients (48%). Focal high‐grade 2 and 3 tumors were seen in 11 (52%) and 3 (14%) patients respectively.

Results

Twenty patients (95%) were alive without disease. Two (10%) had relapse, one with local recurrence and another with local recurrence and lung metastasis. Of eight marginal procedures performed, 2 turned out to have histologically tumor‐positive margins, both of whom later developed relapses. All patients with histologically negative margins remained disease‐free. Presence of intramedullary extension and focal high‐grade tumor was not significantly associated with relapse.

Conclusions

A marginal but histologically negative margin of excision appears adequate for parosteal osteosarcoma. However, long‐term follow‐up is warranted for monitoring of rare incidences of local recurrences or distant metastases. J. Surg. Oncol. 2008;97:146–149. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


COPS3 amplification and clinical outcome
✍ Taiqiang Yan; Jay S. Wunder; Nalan Gokgoz; Mona Gill; Sasha Eskandarian; Robert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract ## BACKGROUND. Amplification of several genes that map to a region of chromosome 17p11.2, including __COPS3,__ was observed in high‐grade osteosarcoma. These genes were also shown to be overexpressed and may be involved in osteosarcoma tumorigenesis. __COPS3__ encodes a subunit of the

Parosteal osteosarcoma: Case report and
✍ Kim M. Hewitt; Gary Ellis; Richard Wiggins; Brandon G. Bentz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Abstract ## Background. The majority of osteosarcoma cases of the head and neck are high‐grade lesions. We present a case and discuss the diagnostic and therapeutic implications of a rare low‐grade parosteal osteosarcoma of the maxilla. ## Methods. A 32‐year‐old man presenting to the Head and

Dedifferentiated parosteal osteosarcoma:
✍ Franco Bertoni; Patrizia Bacchini; Eric L. Staals; Peter Davidovitz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

## Abstract ## BACKGROUND Dedifferentiated parosteal osteosarcoma (DPOS) is a variant of osteosarcoma in which a high‐grade sarcoma coexists with a conventional parosteal osteosarcoma (c‐POS), either at presentation (synchronous type) or at the time of recurrence (metachronous type). Only approxim